Files

Action Filename Description Size Access License Resource Version
Show more files...

Abstract

Photodynamic therapy (PDT), which is based on the activation of photosensitizers with light, can be used to reduce plaque burden. We hypothesized that intra-arterial photosensitizer administration and photo-activation will lead to high and rapid accumulation within the plaque with reduced systemic adverse effects. Thus, this intra-arterial PDT would be expected to have less side effects and due to the short time involved would be compatible with percutaneous coronary interventions. Aim: We characterized the dose-dependent uptake and efficacy of intra-arterial PDT using Liposomal Verteporfin (Visudyne (R)), efficient for cancer-PDT but not tested before for PDT of atherosclerosis. Methods and Results: Visudyne (R) (100, 200, and 500 ng/ml) was perfused for 530 min in atherosclerotic aorta isolated from ApoE(-/-) mice. The fluorescence Intensity (FI) after 15 min of Visudyne (R) perfusion increased with doses of 100 (FI-5.5 +/- 1.8), 200 (FI-31.9 +/- 1.9) or 500 ng/ml (FI-42.9 +/- 1.2). Visudyne (R) (500 ng/ml) uptake also increased with the administration time from 5 min (FI-9.8 +/- 2.5) to 10 min (FI-23.3 +/- 3.0) and 15 min (FI-42.9 +/- 3.4) before reaching saturation at 30 min (FI-39.3 +/- 2.4) contact. Intra-arterial PDT (Fluence: 100 and 200 J/cm(2), irradiance-334 mW/cm(2)) was applied immediately after Visudyne (R) perfusion (500 ng/ml for 15 min) using a cylindrical light diffuser coupled to a diode laser (690 nm). PDT led to an increase of ROS (Dihydroethidium; FI-6.9 +/- 1.8, 25.3 +/- 5.5, 43.4 +/- 13.9) and apoptotic cells (TUNEL; 2.5 +/- 1.6, 41.3 +/- 15.3, 58.9 +/- 6%), mainly plaque macrophages (immunostaining; 0.3 +/- 0.2, 37.6 +/- 6.4, 45.3 +/- 5.4%) respectively without laser irradiation, or at 100 and 200 J/cm2. Limited apoptosis was observed in the medial wall (0.5 +/- 0.2, 8.5 +/- 4.7, 15.3 +/- 12.7%). Finally, Visudyne (R)-PDT was found to be associated with reduced vessel functionality (Myogram). Conclusion: We demonstrated that sufficient accumulation of Visudyne (R) within plaque could be achieved in short-time and therefore validated the feasibility of local intravascular administration of photosensitizer. Intra-arterial Visudyne (R)-PDT preferentially affected plaque macrophages and may therefore alter the dynamic progression of plaque development.

Details

Actions

Preview